RODOLICO, Carmelo
 Distribuzione geografica
Continente #
EU - Europa 12.217
NA - Nord America 10.067
AS - Asia 6.736
SA - Sud America 2.363
AF - Africa 187
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 31.587
Nazione #
US - Stati Uniti d'America 9.874
RU - Federazione Russa 6.327
SG - Singapore 2.853
BR - Brasile 2.010
CN - Cina 1.914
IE - Irlanda 1.499
SE - Svezia 1.162
HK - Hong Kong 787
IT - Italia 641
DE - Germania 577
UA - Ucraina 458
FR - Francia 393
VN - Vietnam 367
FI - Finlandia 321
PL - Polonia 314
GB - Regno Unito 234
IN - India 177
AR - Argentina 128
TR - Turchia 95
CA - Canada 92
BD - Bangladesh 82
NL - Olanda 70
BE - Belgio 59
ZA - Sudafrica 58
ID - Indonesia 55
MX - Messico 54
VE - Venezuela 52
EC - Ecuador 51
IQ - Iraq 51
AT - Austria 43
JP - Giappone 42
PK - Pakistan 41
CO - Colombia 40
UZ - Uzbekistan 40
MA - Marocco 29
PY - Paraguay 29
ES - Italia 27
TN - Tunisia 23
CI - Costa d'Avorio 19
CZ - Repubblica Ceca 19
AZ - Azerbaigian 17
CL - Cile 17
KE - Kenya 17
LT - Lituania 17
PE - Perù 17
IL - Israele 16
JO - Giordania 16
MY - Malesia 16
AE - Emirati Arabi Uniti 15
IR - Iran 14
KZ - Kazakistan 14
NP - Nepal 14
SA - Arabia Saudita 14
EG - Egitto 12
PH - Filippine 12
UY - Uruguay 11
DO - Repubblica Dominicana 10
LB - Libano 10
OM - Oman 10
TH - Thailandia 10
DZ - Algeria 9
JM - Giamaica 8
KG - Kirghizistan 8
AM - Armenia 7
BO - Bolivia 7
AU - Australia 6
EU - Europa 6
GT - Guatemala 6
KR - Corea 6
PA - Panama 6
PS - Palestinian Territory 6
CH - Svizzera 5
RO - Romania 5
AL - Albania 4
BY - Bielorussia 4
GR - Grecia 4
KW - Kuwait 4
NI - Nicaragua 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
CR - Costa Rica 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
LV - Lettonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
DK - Danimarca 2
GA - Gabon 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
Totale 31.550
Città #
Moscow 1.911
Dublin 1.490
Singapore 1.466
Ashburn 1.407
Dallas 1.172
Chandler 1.072
Jacksonville 938
Hong Kong 785
Nyköping 710
Beijing 674
San Jose 376
The Dalles 354
Warsaw 299
Princeton 274
Los Angeles 249
Lauterbourg 240
Medford 229
Cambridge 225
Ann Arbor 201
Des Moines 192
Dearborn 174
Messina 146
São Paulo 143
New York 139
Munich 129
Buffalo 125
Ho Chi Minh City 123
Boardman 109
Tianjin 100
Wilmington 85
Council Bluffs 75
Guangzhou 75
Hanoi 74
Shenyang 73
Jinan 72
San Mateo 70
Nanjing 64
Belo Horizonte 63
Frankfurt am Main 63
Turku 60
Orem 59
Rio de Janeiro 58
Redondo Beach 57
Rome 52
Bremen 50
Woodbridge 48
Brooklyn 46
Lancaster 45
Brussels 41
Hyderabad 40
Ningbo 39
Istanbul 38
Santa Clara 38
Tokyo 38
Shanghai 35
Tashkent 35
Hebei 34
Pune 33
Seattle 32
Brasília 31
Chennai 31
Helsinki 31
Hangzhou 30
Houston 30
Milan 30
Catania 29
Atlanta 28
Haikou 28
Zhengzhou 28
Montreal 27
Dong Ket 26
Falls Church 26
Stockholm 26
Amsterdam 25
Campinas 25
Nuremberg 25
Porto Alegre 25
San Francisco 25
Shenzhen 25
Vienna 25
Curitiba 24
Johannesburg 24
Boston 23
Denver 22
Guayaquil 22
Manchester 21
Mumbai 21
Dhaka 20
Taizhou 20
Abidjan 19
Baghdad 19
Jakarta 19
Salvador 19
Toronto 19
London 18
Ottawa 18
Baku 17
Buenos Aires 17
Fortaleza 17
Norwalk 17
Totale 18.016
Nome #
Clinical and pathological features of focal myositis 248
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 245
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 218
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
Le sindromi miasteniche congenite 211
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 208
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 205
A life threatening case of β-enolase deficiency 199
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 197
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy 191
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 189
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 189
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy. 188
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 188
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 186
Hippo signaling pathway is altered in Duchenne muscular dystrophy 186
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 175
ANT1 is reduced in sporadic inclusion body myositis. 175
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 174
Central and peripheral autonomic failure in cold induced sweating syndrome type 1 174
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 173
Advances in assessing myotonia: Can sensor-engineered glove have a role? 173
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 172
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 168
A standardized clinical evaluation of patients affected by facioscapulohumeralmuscular dystrophy: The FSHD clinical score. 168
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 166
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 165
Apoptosis and apoptosis-related proteins in thyroid myopathies 164
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 164
Cardiovascular autonomic control in Becker muscular dystrophy 164
Autoimmune juvenile limb-girdle myasthenia 164
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 163
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 163
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 163
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 163
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 161
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 160
Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis 159
Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy 158
Toward a more personalized motor function rehabilitation in myotonic dystrophy type 1: The role of neuroplasticity 158
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Italian recommendations for the diagnosis and treatment of myasthenia gravis 157
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 156
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 153
Miotonia congenita, epilessia, schizofrenia: un'insolita associazione 152
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 152
A 5-year clinical follow-up study from the Italian National Registry for FSHD 152
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 151
Fatal R631C mutation is also present in the adult form of CPTII deficiency 150
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 149
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 149
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 149
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 149
Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. 148
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 147
A robust tool to quantify disability in patients affected by facio-scapulo-humeral muscular dystrophy. 147
Involvement of miR-126 in autoimmune disorders 147
Severe rhabdomyolysis in a patient with “Heat Stroke” 146
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 146
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 146
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 145
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 145
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 144
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 141
Endocrine myopathies: Clinical and histopathological features of the major forms 141
An unusual association of dominant optic atrophy with OPA1 mutations and parkinsonian syndrome. 140
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 140
MuSK-Associated Myasthenia Gravis: Clinical Features and Management 140
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 139
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 139
Juvenile limb-girdle myasthenia gravis 139
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 139
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 139
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 138
Chanarin-Dorfman disease (CDD): clinical, genetic and neuroradiological aspects in an adult case followed over 25 years 137
Calpain 3 deficiency in Quail Eater's disease 137
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 137
Rituximab in AChR subtype of myasthenia gravis: systematic review 137
Amyloid myopathy presenting with rhabdomyolysis 136
Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. 136
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 136
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 135
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 135
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 135
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 135
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 134
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 133
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 133
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 132
Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy 132
Amyloid myopathy presenting with rhabdomyolysis. 131
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 129
Malattia di Chanarin-Dorfman: aspetti clinici, gemetici e neuroradiologici di un caso adulto seguito per 25 anni 128
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 128
Expression of the trascription factor NFkB in different muscular dystrophies 128
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 127
Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series 127
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 126
Tetraplegia flaccida dopo prolungata infusione di cisatracurio 126
Progressiva comparsa di miopatia, neuropatia e miastenia in un paziente con ipotiroidismo primario autoimmune. 125
Totale 15.657
Categoria #
all - tutte 105.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021413 0 0 0 0 0 0 0 0 0 228 119 66
2021/20221.656 13 215 20 71 82 23 169 76 35 174 207 571
2022/20234.254 343 361 182 298 343 428 42 262 1.818 19 120 38
2023/20241.025 97 174 70 86 78 208 34 46 2 82 31 117
2024/20255.383 88 41 77 312 219 148 138 1.113 1.330 345 560 1.012
2025/202615.120 809 1.124 1.251 1.077 1.246 3.340 1.930 1.874 1.846 623 0 0
Totale 32.143